Bundamedik Tbk PT (BMHS) — Cash Flow Quality Index
Bundamedik Tbk PT (BMHS) has a Cash Flow Quality Index of 1172.10x as of December 2025. Operating cash flow of Rp199.64 Billion exceeds net income of Rp170.33 Million, indicating high earnings quality where cash backs reported profits. Explore BMHS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bundamedik Tbk PT Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Bundamedik Tbk PT across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Bundamedik Tbk PT (BMHS) cash flow conversion.
Annual Cash Flow Quality Index for Bundamedik Tbk PT (2018–2025)
Year-by-year earnings quality comparison for Bundamedik Tbk PT.
| Year | Quality Index | Operating CF (IDR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 20.18x | Rp250.62 Billion | Rp12.42 Billion | ▲ +609.3% |
| 2024 | 2.85x | Rp33.98 Billion | Rp11.94 Billion | ▼ -58.7% |
| 2023 | 6.89x | Rp51.44 Billion | Rp7.46 Billion | ▲ +274.3% |
| 2022 | 1.84x | Rp237.47 Billion | Rp128.93 Billion | ▲ +13.1% |
| 2021 | 1.63x | Rp349.44 Billion | Rp214.49 Billion | ▼ -24.0% |
| 2020 | 2.14x | Rp190.36 Billion | Rp88.79 Billion | ▼ -52.5% |
| 2019 | 4.51x | Rp89.72 Billion | Rp19.89 Billion | ▼ -47.2% |
| 2018 | 8.54x | Rp43.79 Billion | Rp5.13 Billion | — |